Karen Wiss to Child
This is a "connection" page, showing publications Karen Wiss has written about Child.
Connection Strength
0.740
-
Garza-Mayers AC, Paquette GM, Harris JE, Wiss K. Narrowband ultraviolet B phototherapy in pediatric vitiligo: A retrospective study. J Am Acad Dermatol. 2023 07; 89(1):135-136.
Score: 0.100
-
McCormack L, Trivedi A, Lal K, Amano S, Elaba ZRP, McIntyre J, Wiss K. Proliferating pilomatricoma in a 9-year-old girl. Pediatr Dermatol. 2020 Nov; 37(6):1187-1188.
Score: 0.085
-
Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: A retrospective review of 110 cases. J Am Acad Dermatol. 2018 03; 78(3):511-514.
Score: 0.070
-
Li AW, Prindaville B, Bateman ST, Gibson TE, Wiss K. Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review. Pediatr Dermatol. 2017 Nov; 34(6):647-655.
Score: 0.069
-
Crombie J, Greenlaw S, Fenner J, Lyle S, Wiss K. Loose anagen hair syndrome in two patients with epidermolysis bullosa simplex, Dowling-Meara type. J Am Acad Dermatol. 2012 Sep; 67(3):e120-1.
Score: 0.049
-
Gray C, Greenlaw SM, Alavian C, Wiss K. Epidermolysis bullosa simplex with mottled pigmentation: a novel KRT14 mutation. J Drugs Dermatol. 2011 Aug; 10(8):926-7.
Score: 0.045
-
Meara EM, Curran DL, Wiss K, Plumptre I. Eosinophilic Plastic Bronchitis in a Child With Palmoplantar Psoriasis Treated With Ustekinumab. Pediatr Dermatol. 2026 Jan-Feb; 43(1):163-165.
Score: 0.030
-
Tang JY, Marinkovich MP, Wiss K, McCarthy D, Truesdale A, Chiou AS, Eid E, McIntyre JK, Bailey I, Furukawa LK, Gorell ES, Harris N, Khosla RK, Peter Lorenz H, Lu Y, Nazaroff J, Grachev ID, Moore AJ. Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial. Lancet. 2025 Jul 12; 406(10499):163-173.
Score: 0.030
-
Pathmarajah P, Eid E, Nazaroff J, So J, Mittal V, Harris N, Li S, Lucky AW, Gorell ES, Peoples KG, Pope E, Lara-Corrales I, Paller AS, Wiss K, Perman MJ, Eichenfield LF, Levy ML, Morel KD, Garc?a-Romero MT, McCuaig CC, Saber M, Marinkovich MP, Oro A, Bruckner AL, Tang JY. Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2025 Apr 28; 192(5):917-925.
Score: 0.029
-
Thapar M, Plumptre I, Wiss K, Scharf M. How to Make a Wick: A Controlled and Accurate Cryotherapy Technique for Benign Lesions. Pediatr Dermatol. 2025 Sep-Oct; 42(5):1105-1107.
Score: 0.029
-
Rangu S, Collins J, Garc?a-Romero MT, Augsburger BD, Bruckner AL, Diaz LZ, Eichenfield LF, Faig W, Gorell ES, Lefferdink R, Lucky AW, Morel KD, Paller AS, Park H, Pastrana-Arellano E, Peoples K, Wiss K, Perman MJ, Castelo-Soccio L. Assessing pain catastrophizing and functional disability in pediatric epidermolysis bullosa patients. Pediatr Dermatol. 2023 May-Jun; 40(3):422-427.
Score: 0.025
-
Barry KK, Plumptre I, Bazewicz CG, Green BP, Treat JR, Hughes M, Morel KD, Wiss K, Liang MG. Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series. Pediatr Dermatol. 2023 Jan; 40(1):90-95.
Score: 0.024
-
Neale H, Plumptre I, Belazarian L, Wiss K, Hawryluk EB. Central nervous system magnetic resonance imaging abnormalities and neurologic outcomes in pediatric patients with congenital nevi: A 10-year multi-institutional retrospective study. J Am Acad Dermatol. 2022 11; 87(5):1060-1068.
Score: 0.024
-
Rork JF, McCormack L, Lal K, Wiss K, Belazarian L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020 Sep; 37(5):811-816.
Score: 0.021
-
Shayegan LH, Levin LE, Galligan ER, Lucky AW, Bruckner AL, Pope E, Lara-Corrales I, Wiss K, McCuaig CC, Garzon MC, Eichenfield LF, Hook KP, Browning JC, Schachner LA, Perman MJ, Castelo-Soccio L, Levy ML, Glick SA, Morel KD. Skin cleansing and topical product use in patients with epidermolysis bullosa: Results from a multicenter database. Pediatr Dermatol. 2020 Mar; 37(2):326-332.
Score: 0.020
-
Tanaka AC, Robbins CC, Wiss K, Chen VM. Frequent corneal abrasions precede scarring and vision loss in epidermolysis bullosa: An international patient survey. J Am Acad Dermatol. 2020 Sep; 83(3):917-919.
Score: 0.020
-
Bensimon J, Wiss K, Banker S. Impact of Camp Discovery volunteerism on provider burnout and empathy. J Am Acad Dermatol. 2020 Aug; 83(2):636-638.
Score: 0.020
-
Feinstein JA, Jambal P, Peoples K, Lucky AW, Khuu P, Tang JY, Lara-Corrales I, Pope E, Wiss K, Hook KP, Levin LE, Morel KD, Paller AS, McCuaig CC, Powell J, Eichenfield LF, Price H, Levy ML, Schachner LA, Browning JC, Bayliss S, Jahnke M, Shwayder T, Glick SA, Bruckner AL. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America. JAMA Dermatol. 2019 02 01; 155(2):196-203.
Score: 0.019
-
St John J, Summe H, Csikesz C, Wiss K, Hay B, Belazarian L. Multiple Caf? au Lait Spots in a Group of Fair-Skinned Children without Signs or Symptoms of Neurofibromatosis Type 1. Pediatr Dermatol. 2016 Sep; 33(5):526-9.
Score: 0.016
-
Fenner JA, Wiss K, Levin NA. Oral cephalexin for acne vulgaris: clinical experience with 93 patients. Pediatr Dermatol. 2008 Mar-Apr; 25(2):179-83.
Score: 0.009
-
Sweeney SM, Wiss K, Mallory SB. Inflammatory tinea pedis/manuum masquerading as bacterial cellulitis. Arch Pediatr Adolesc Med. 2002 Nov; 156(11):1149-52.
Score: 0.006